Disposable Medical Sensors Market Is Predicted To Grow Swiftly Due To Rising Demand In Clinics & Home Diagnostic Devices Till 2025: Grand View Research, Inc.

The global disposable medical sensors market is expected to reach USD 12.3 billion by 2025, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic diseases has been observed to be a major factor driving growth which is demanding for better healthcare service provision by high quality diagnostic and monitoring devices. These devices will enable patients to self-monitor and along with easy and affordable usage. In addition, the rapidly rising technological advancements is expected to bring in innovation in medical sensors.

The market is also being driven by government initiatives to fund and encourage R&D which in turn will help in launching innovative products. For instance, the government of India increased the health expenditure from 1.4% to 2.5% for innovations, and other healthcare services. Innovations in medical sensors not only instill ease of use but also assist in making the device portable and automated.

On the basis of product, the biosensor segment is accounted to be the spearhead in 2016 and is expected to maintain its dominance over the forecast period. This can be attributed to the rising demand for rapid and accurate diagnostic kit. Development of such diagnostic tools is expected to further create new growth opportunities for biosensors, thereby supporting growth of the disposable medical sensors market. Launching of new products are expected to fuel market growth. For instance, Raiing Medical launched wearable thermometer in 2016 that is rechargeable and waterproof. Similarly, MEMSIC Inc. launched new pressure sensor in 2017 which is used in breath detection.

U.S. disposable medical sensors market by product, 2014 - 2025 (USD Million)



Browse full research report on Disposable Medical Sensors Market: http://www.grandviewresearch.com/industry-analysis/disposable-medical-sensors-industry                    

Further key findings from the report suggest:

  • Globally, disposable medical sensors witnessed lucrative growth in 2016 and are expected to grow at a CAGR of 10.2% from 2017 to 2025
  • Biosensor segment has been observed to be the largest product segment in 2016 and is estimated to generate revenue of over USD 6.03 billion by 2025
  • On the basis of application, the diagnostic segment is expected to dominate the market space. This is attributed to the increasing incidence of various infectious and other chronic conditions, along with the growing awareness among the population.
  • The industry in Asia Pacific is expected to witness substantial growth over the next decade owing to the increasing incidence of diseases and the geriatric population with high unmet healthcare needs.
  • Some of the key players in this industry are Medtronic, Philips, GE Healthcare, OmniVision Technologies, Sensiorion AG, Smiths Medical, and Analog Devices.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices    

Grand View Research has segmented the global disposable medical sensors market on the basis of product, distribution channel, end use, and region:

Product Outlook (Revenue, USD Million, 2014 - 2025)
  • Biosensors
  • Pressure sensors
  • Accelerometer sensors
  • Temperature sensors
  • Image sensors
Type Outlook (Revenue, USD Million, 2014 - 2025)
  • Strip sensors
  • Wearable sensors
  • Implantable sensors
  • Invasive sensors
  • Ingestible sensors
Application Outlook (Revenue, USD Million, 2014 - 2025)
  • Diagnostic
  • Therapeutic
  • Patient monitoring
Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East Asia
    • South Africa
    • Saudi Arabia
Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-disposable-medical-sensors-market         
      
About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Epigenetics Market to Observe Strong Development by 2022

The global  epigenetics market  is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.  Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.  Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.  Technology advancements in the field of epigenetics especially pertaining to t
Read more

Increasing Incidences Of M&A Of CDMO/CRO With Big Pharma Companies To Drive Life Sciences BPO Market Growth Till 2024: Grand View Research, Inc.

Image
The  life sciences BPO market  is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services.  The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources.  North America life sciences BPO market, by services, 2013 - 2024 (USD Billion) In order to cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth
Read more

U.S. Telehealth Market Is To Be $2.83 Billion By 2022: Grand View Research, Inc.

Image
U.S. telehealth market  is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research Inc. Increasing access to basic healthcare is the major aim of telehealth along with improved healthcare quality and patient safety by early detection and diagnosis. According to a report published by the Agency for Health Care Research and Quality (AHRQ), implementation of telehealth solution improves quality of care delivery to patients.  The rising demand for self care and independent living along with the concept of home care is highly appealing to the population. The Rhode Island Partnership for Home Care reported that in 2014, over 20,000 citizens demanded for home care that led to approximately 1,000,000 visits by healthcare providers. Advantages that drive the higher adoption for home care include better psychological impact on patients, provision of friendly environment, care provision as per patient needs, and cost-effectiveness.  U.S. telehealth
Read more